Manulife (Manufacturers Life Insurance)’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-7,965
| Closed | -$285 | – | 3072 |
|
|
2021
Q4 | $285 | Buy |
7,965
+68
| +0.9% | +$2.72K | ﹤0.01% | 2635 |
|
|
2021
Q3 | $336K | Sell |
7,897
-429
| -5% | -$17.7K | ﹤0.01% | 2580 |
|
|
2021
Q2 | $360K | Buy |
8,326
+45
| +0.5% | +$1.92K | ﹤0.01% | 2676 |
|
|
2021
Q1 | $338K | Sell |
8,281
-183
| -2% | -$6.94K | ﹤0.01% | 2535 |
|
|
2020
Q4 | $383K | Sell |
8,464
-37
| -0.4% | -$1.4K | ﹤0.01% | 2366 |
|
|
2020
Q3 | $301K | Hold |
8,501
| – | – | ﹤0.01% | 2294 |
|
|
2020
Q2 | $296K | Sell |
8,501
-64
| -0.7% | -$2.11K | ﹤0.01% | 2264 |
|
|
2020
Q1 | $248K | Buy |
8,565
+584
| +7% | +$23.6K | ﹤0.01% | 2199 |
|
|
2019
Q4 | $414K | Sell |
7,981
-430
| -5% | -$25K | ﹤0.01% | 2156 |
|
|
2019
Q3 | $453K | Sell |
8,411
-312
| -4% | -$16K | ﹤0.01% | 2078 |
|
|
2019
Q2 | $354K | Buy |
+8,723
| New | +$318K | ﹤0.01% | 2261 |
|
|
2018
Q3 | – | Sell |
-11,257
| Closed | -$360K | – | 2960 |
|
|
2018
Q2 | $360K | Buy |
11,257
+438
| +4% | +$18K | ﹤0.01% | 2646 |
|
|
2018
Q1 | $539K | Sell |
10,819
-218
| -2% | -$12.3K | ﹤0.01% | 2274 |
|
|
2017
Q4 | $595K | Buy |
11,037
+50
| +0.5% | +$2.77K | ﹤0.01% | 2203 |
|
|
2017
Q3 | $637K | Sell |
10,987
-240
| -2% | -$12.5K | ﹤0.01% | 2102 |
|
|
2017
Q2 | $554K | Buy |
11,227
+89
| +0.8% | +$4.1K | ﹤0.01% | 2207 |
|
|
2017
Q1 | $484K | Buy |
11,138
+1,332
| +14% | +$63.6K | ﹤0.01% | 2212 |
|
|
2016
Q4 | $480K | Buy |
9,806
+158
| +2% | +$7.3K | ﹤0.01% | 2120 |
|
|
2016
Q3 | $462K | Sell |
9,648
-78
| -0.8% | -$3.85K | ﹤0.01% | 2132 |
|
|
2016
Q2 | $522K | Sell |
9,726
-159
| -2% | -$7.49K | ﹤0.01% | 1999 |
|
|
2016
Q1 | $445K | Buy |
9,885
+105
| +1% | +$4.26K | ﹤0.01% | 2036 |
|
|
2015
Q4 | $373 | Hold |
9,780
| – | – | ﹤0.01% | 2205 |
|
|
2015
Q3 | $311 | Buy |
9,780
+306
| +3% | +$10.7K | ﹤0.01% | 2314 |
|
|
2015
Q2 | $313 | Sell |
9,474
-49
| -0.5% | -$1.75K | ﹤0.01% | 2471 |
|
|
2015
Q1 | $392 | Buy |
9,523
+333
| +4% | +$13.5K | ﹤0.01% | 2230 |
|
|
2014
Q4 | $375 | Sell |
9,190
-315
| -3% | -$12.3K | ﹤0.01% | 2177 |
|
|
2014
Q3 | $348 | Buy |
9,505
+149
| +2% | +$6.44K | ﹤0.01% | 2234 |
|
|
2014
Q2 | $433K | Sell |
9,356
-49
| -0.5% | -$2.18K | ﹤0.01% | 2138 |
|
|
2014
Q1 | $387 | Sell |
9,405
-197
| -2% | -$7.32K | ﹤0.01% | 2258 |
|
|
2013
Q4 | $366 | Sell |
9,602
-257
| -3% | -$7.93K | ﹤0.01% | 2276 |
|
|
2013
Q3 | $236 | Buy |
9,859
+379
| +4% | +$8.51K | ﹤0.01% | 2523 |
|
|
2013
Q2 | $161K | Buy |
+9,480
| New | +$137K | ﹤0.01% | 2742 |
|
Other funds holding ANIK
TI
FWIA
Manulife (Manufacturers Life Insurance)'s ANIK Position: Q1 2022 in Review
Manulife (Manufacturers Life Insurance) sold out of Anika Therapeutics (ANIK) in Q1 2022, closing a stake of 7,965 shares — an estimated $285 sold.
Manulife (Manufacturers Life Insurance) first reported a position in ANIK in Q2 2013 and held it in 32 quarters. The position peaked at $637K in Q3 2017. 119 funds tracked by Wall St. Rank hold ANIK as of Q1 2022.
- Manulife (Manufacturers Life Insurance) reported no remaining Anika Therapeutics position as of Q1 2022 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 7,965 Anika Therapeutics shares in Q1 2022, an estimated $285.
- Manulife (Manufacturers Life Insurance) first reported a position in Anika Therapeutics in Q2 2013 and held it in 32 quarters.
- Manulife (Manufacturers Life Insurance)'s Anika Therapeutics position peaked at $637K in Q3 2017.
- 119 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2022.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2022, filed 20 May 2022.